We are monitoring the impact of COVID-19 & Recession alarm on Europe Cell Based Assay Market Get in touch with us for detailed analysis Know More
Share on

Europe Cell-Based Assay Market Research Report – Segmented By Type of Product, Technology, Application, End Users and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2022 to 2027)

Published: January, 2022
ID: 2127
Pages: 1445

Europe Cell-Based Assay Market Size (2022 to 2027)

The size of the Cell-Based Assay Market in Europe was worth USD 4.47 billion in 2022 and is estimated to be growing at a CAGR of 10.84% to reach USD 7.47 billion by 2027. Europe is the second-largest cell-based assay market.

The rising incidence of chronic cases, growing demand for cell-based assays are majorly driving growth for the European cell-based assay market. Additionally, increasing R & D activities towards the innovations to battle against deadly diseases such as cancer, cardiovascular diseases, and others are estimated to add fuel to the market's growth rate in Europe. Wide usage of these cell-based assays in applications such as diagnostics and pathology, rise in funds by government and other private sectors for R&D are predicted to favor the European market during the forecast period. Furthermore, growing awareness related to the applications of cell-based assays is a positive sign.

Lack of experienced professionals is to hinder the cell-based assay market growth during the analysis period. Also, the high cost of the instruments and strict regulatory recommendations may hamper the growth. Moreover, boundaries on reagent use may also obstruct the market.

This research report on the Europe Cell-Based Assay Market has been segmented and sub-segmented into the following categories:

By Type Of Product: 

  • Cell Lines
    • Primary Cell Lines
    • Stem Cell Lines
    • Immortalized Cell Lines
  • Assay Ready Kits
  • Cell Culture Kits
  • Reagents & Consumables
  • Ligands & Inhibitors

By Technology: 

  • Automated Handling
  • Flow Cytometry
  • Label-Free Detection
  • High Content Screening

By Application: 

  • Drug Discovery
  • ADME Research

By End Users: 

  • Academia
  • Biotechnology
  • Pharmaceuticals
  • CRO

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, Spain and Italy are the fastest emerging markets in the European region for the cell-based assay market. An increase in the adoption of cell-based assays platforms and enormous biotechnology and pharmaceutical companies in the area augment market growth. Advance technologies in activities like improved systems, innovative and disposable columns, better-performing resins, and alternative accessories square measures help the cell-based assays market grow considerably. Growing expenditure by the government sector to lessen the death rates from cancer is responsible for market growth.

Noteworthy companies leading the European Cell-Based Assay Market profiled in this report are Thermo Fisher Scientific Inc., Becton & Dickinson and Company, Merck & Co. Inc., Cell Signalling Technology Inc., PerkinElmer Inc., Danaher Corporation, General Electric Company, Cisbio Bioassays, DiscoveRx, Ametek Inc., Bio-Rad Laboratories, Roche Diagnostics, GE Healthcare, and Promega Corporation.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type of Product                        

                                5.1.1 Introduction           

                                5.1.2 Cell Lines  

                                                5.1.2.1 Primary Cell Lines

                                                5.1.2.2 Stem Cell Lines

                                                5.1.2.3 Immortalized Cell Lines

                                5.1.3 Assay Ready Kits   

                                5.1.4 Cell Culture Kits     

                                5.1.5 Reagents & Consumables

                                5.1.6 Ligands & Inhibitors             

                                5.1.7  Y-o-Y Growth Analysis, By Type of Product              

                                5.1.8  Market Attractiveness Analysis, By Type of Product            

                                5.1.9  Market Share Analysis, By Type of Product              

                5.2 Technology                 

                                5.2.1 Introduction           

                                5.2.2 Automated Handling          

                                5.2.3 Flow Cytometry    

                                5.2.4 Label-Free Detection          

                                5.2.5 High Content Screening     

                                5.2.6 High Throughput Screening             

                                5.2.7  Y-o-Y Growth Analysis, By Technology       

                                5.2.8  Market Attractiveness Analysis, By Technology     

                                5.2.9  Market Share Analysis, By Technology       

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Drug Discovery      

                                5.3.3 ADME Research    

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Academia

                                5.4.3 Biotechnology       

                                5.4.4 Pharmaceuticals   

                                5.4.5 CRO            

                                5.4.6  Y-o-Y Growth Analysis, By End User            

                                5.4.7  Market Attractiveness Analysis, By End User          

                                5.4.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type of Product

                                                6.1.3.3 By Technology

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type of Product

                                                6.1.4.3 By Technology

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technology

                                                6.1.5.3 By Type

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Thermo Fisher Scientific Inc.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Becton                          

                8.3 Dickinson and Company                        

                8.4 Merck & Co. Inc.                       

                8.5 Cell Signalling Technology Inc.                            

                8.6 PerkinElmer Inc.,                      

                8.7 Danaher Corporation                             

                8.8 General Electric Company                    

                8.9 Cisbio Bioassays                        

                8.10 DiscoveRx                 

                8.11 Ametek Inc.                             

                8.12 -Rad Laboratories                  

                8.13 Roche Diagnostics                 

                8.14 GE Healthcare                         

                8.15 Promega Corporation                          

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Europe Cell Based Assay Market, By Type of Product, From 2022 - 2027 (USD Million)
  2. Europe Cell Lines Market, By Region, From 2022 - 2027 (USD Million)
  3. Europe Assay Ready Kits Market, By Region, From 2022 - 2027 (USD Million)
  4. Europe Cell Culture Kits Market, By Region, From 2022 - 2027 (USD Million)
  5. Europe Reagents & Consumables Market, By Region, From 2022 - 2027 (USD Million)
  6. Europe Ligands & Inhibitors Market, By Region, From 2022 - 2027 (USD Million)
  7. Europe Cell Based Assay Market, By Technology , From 2022 - 2027 (USD Million)
  8. Europe Automated Handling Market, By Region, From 2022 - 2027 (USD Million)
  9. Europe Flow Cytometry Market, By Region, From 2022 - 2027 (USD Million)
  10. Europe Label-Free Detection Market, By Region, From 2022 - 2027 (USD Million)
  11. Europe High Content Screening Market, By Region, From 2022 - 2027 (USD Million)
  12. Europe High Throughput Screening Market, By Region, From 2022 - 2027 (USD Million)
  13. Europe Cell Based Assay Market, By Application, From 2022 - 2027 (USD Million)
  14. Europe Drug Discovery Market, By Region, From 2022 - 2027 (USD Million)
  15. Europe ADME Research Market, By Region, From 2022 - 2027 (USD Million)
  16. Europe Cell Based Assay Market, By End User, From 2022 - 2027 (USD Million)
  17. Europe Academia Market, By Region, From 2022 - 2027 (USD Million)
  18. Europe Biotechnology Market, By Region, From 2022 - 2027 (USD Million)
  19. Europe Pharmaceuticals Market, By Region, From 2022 - 2027 (USD Million)
  20. Europe CRO Market, By Region, From 2022 - 2027 (USD Million)
  21. U.K. Cell Based Assay Market, By Type of Product, From 2022 - 2027 (USD Million)
  22. U.K. Cell Based Assay Market, By Technology , From 2022 - 2027 (USD Million)
  23. U.K. Cell Based Assay Market, By Application, From 2022 - 2027 (USD Million)
  24. U.K. Cell Based Assay Market, By End User, From 2022 - 2027 (USD Million)
  25. Germany Cell Based Assay Market, By Type of Product, From 2022 - 2027 (USD Million)
  26. Germany Cell Based Assay Market, By Technology , From 2022 - 2027 (USD Million)
  27. Germany Cell Based Assay Market, By Application, From 2022 - 2027 (USD Million)
  28. Germany Cell Based Assay Market, By End User, From 2022 - 2027 (USD Million)
  29. France Cell Based Assay Market, By Type of Product, From 2022 - 2027 (USD Million)
  30. France Cell Based Assay Market, By Technology , From 2022 - 2027 (USD Million)
  31. France Cell Based Assay Market, By Application, From 2022 - 2027 (USD Million)
  32. France Cell Based Assay Market, By End User, From 2022 - 2027 (USD Million)
  33. Italy Cell Based Assay Market, By Type of Product, From 2022 - 2027 (USD Million)
  34. Italy Cell Based Assay Market, By Technology , From 2022 - 2027 (USD Million)
  35. Italy Cell Based Assay Market, By Application, From 2022 - 2027 (USD Million)
  36. Italy Cell Based Assay Market, By End User, From 2022 - 2027 (USD Million)
  37. Spain Cell Based Assay Market, By Type of Product, From 2022 - 2027 (USD Million)
  38. Spain Cell Based Assay Market, By Technology , From 2022 - 2027 (USD Million)
  39. Spain Cell Based Assay Market, By Application, From 2022 - 2027 (USD Million)
  40. Spain Cell Based Assay Market, By End User, From 2022 - 2027 (USD Million)
  41. Europe Cell Based Assay Market, By Cell Lines, From 2022 - 2027 (USD Million)
  42. Europe Primary Cell Lines Market, By Region, From 2022 - 2027 (USD Million)
  43. Europe Stem Cell Lines Market, By Region, From 2022 - 2027 (USD Million)
  44. Europe Immortalized Cell Lines Market, By Region, From 2022 - 2027 (USD Million)
  45. U.K. Cell Based Assay Market, By Cell Lines, From 2022 - 2027 (USD Million)
  46. Germany Cell Based Assay Market, By Cell Lines, From 2022 - 2027 (USD Million)
  47. France Cell Based Assay Market, By Cell Lines, From 2022 - 2027 (USD Million)
  48. Italy Cell Based Assay Market, By Cell Lines, From 2022 - 2027 (USD Million)
  49. Spain Cell Based Assay Market, By Cell Lines, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample